BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03898180-completion@plaintrial.com
DTSTAMP:20261029T034809Z
DTSTART;VALUE=DATE:20240520
SUMMARY:Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-790
 2/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose T
 umors Express Programmed Cell Death-Ligand 1 and in Participants Ineligibl
 e for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-0
 11) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03898180
URL:https://plaintrial.com/trial/NCT03898180
END:VEVENT
END:VCALENDAR